acute coronary syndrome Flashcards

1
Q

define acute coronary syndrome

A

a subclassification of ischemic heart disease which consists of the conditions:
- unstable angina
- non-ST elevation myocardial infarction (NSTEMI)
- ST-elevation myocardial infarction (STEMI)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

most common cause of acute coronary syndrome

A
  • rupture of atherosclerotic plaque resulting in thrombus formation in artery
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what is the rate of artery occlusion in each of the conditions?

A

unstable angina and NSTEMI - partial occlusion

STEMI - complete occlusion because of thrombus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

which conditions lead to myocardial necrosis?

A

STEMI and NSTEMI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

presentation - the big 5

A

Smoking
Hypertension
Diabetes mellitus
Hypercholesterolaemia
Family history

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

signs and symptoms

A

Crushing/pressure-like chest pain that can radiate to the jaw/left arm

Typical symptoms due to reduced CO:
- Breathlessness
- Dizziness
- Weakness

Bilateral leg oedema may present if congestive heart failure (CHF) develops

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

STEMI investigations

A

ECG – differentiates between NSTEMI and STEMI

Biomarkers of myocyte necrosis
- Troponin T and I
- CK-MB
- Lactate dehydrogenase (outdated due to troponin testing)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

modifiable risk factors (7)

A

Hypertension
Hyperglycaemia (DM)
Smoking
Alcohol
Hypercholesterolaemia
Obesity/inactivity
Stress

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

non-modifiable risk factors

A

Age
Sex (men and post-menopausal women)
Genetic/Family History

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

differentiation on ECG

A

STEMI - ST elevation
NSTEMI and UA - ST not elevated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

if someone came in and had ecg showing st long segment what would you do?

A

automatically make a diagnosis of myocardial infarction and give MONA medication then organise PCI to revascularise the occlusion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

differentiation on troponin level

A

UA - no raised troponin
NSTEMI and STEMI - do have raised troponin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

primary prevention (before ACS has developed)

A
  • Lifestyle advice (e.g. exercise, stop smoking, reduce alcohol, fats and salt, eat more fruit & veg)
  • QRISK score
    If above 10%, consider statins
  • ACE inhibitor if hypertensive
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

secondary prevention - after a patient has developed ACS

A

mnemonic - ABAS
- aspirin + antiplatelet 12 months
- Beta-blocker
- ACE inhibitor
- Statin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

immediate management for acute presentation MI

A

mnemonic - MONA(C)
- Morphine IV
- Oxygen if low
- Nitrates
- Aspirin 300mg loading dose
- 2nd antiplatelet drug eg - (C)lopidogrel (ONLY IN STEMI)
PCI

NSTEMI
MONA
coronary angiogram either urgently or later, depending on risk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

STEMI treatment <2hrs MI

A

percutaneous coronary intervention:
- balloon angioplasty or stenting

IF NOT
thrombolytic therapy
- Promotes plasminogen conversion to plasmin to break down fibrin clots
- First line is Tissue Plasminogen Activator (TPAs)
- Streptokinase is alternative

17
Q

NSTEMI treatment <2hrs MI

A
  • PCI
  • thrombolytic therapy not inducated
18
Q

criteria for PPCI for STEMI

A

ST elevation >2mm in 2 contiguous chest leads or >1mm in 2 contiguous limb leads (ie. territorial)
~Chest pain or other evidence of ischaemia

19
Q

how aspirin works

A

blocks COX1 in low doses which inhibits thromboxine A2 - inhibits vasoconstriction

blocks COX2 - acts as an antiinflammatory

20
Q

clopidogrel

A

P2Y12 inhibitor
prevents clotting
pro-drug

21
Q

P2Y12 inhibitors

A

clopidogrel - pro-drug
prasugrel - not a pro-drug

22
Q

why are PY12 inhibitors given

A

to prevent clotting - blood thinners

23
Q

drugs - if patients develop complications from MI - for heart failure

A

milterocorticoid receptor antagonists
implantable cardioverter defibrillator - special pacemaker

24
Q

Complications of MI

A
  • Arrhythmia
  • LV failure – pulmonary oedema, cardiogenic shock
25
Q

Acute MI - Definition / diagnosis

A

Consistent clinical setting for myocardial necrosis PLUS
Rise and/or fall in cardiac biomarkers with at least one value >upper reference limit PLUS at least one of:
Symptoms of ischaemia
New/presumed new ST/T changes or LBBB
Development of pathological Q waves
Imaging (eg. echo, MR, LV gram) shows new loss of viable myocardium/RWMA
Intracoronary thrombus on angiography or autopsy

Type 1 MI = Spontaneous plaque rupture, ulceration, erosion, fissure, dissection with intraluminal thrombus

26
Q

unstable angina

A
  • considered to be present in patients with ischaemic symptoms suggestive of an ACS and no elevation in troponins, with or without electrocardiogram changes indicative of ischaemia
  • however, as a rise in troponins may take some hours it may be indistinguishable for NSTEMI initially and is therefore treated the same until the troponin result is known
27
Q

A 60-year-old man presents with acute chest pain and dizziness. His ECG shows ST elevation in leads II, III, and aVF, and ST depression in leads I and aVL.

Which of the following best explains the occurrence of reciprocal ST depression in leads opposite to the infarcted area?

A

electrical acitivity moving away from the infercted area produces reciprocal changes in opposit leads

28
Q

Why is dual antiplatelet therapy (DAPT) recommended in the management of acute coronary syndromes (ACS), including STEMI?

A

using 2 antiplatelet drugs such as clopidogrel and aspirin to prevent further clotting in the coronary arteries

29
Q

What is the role of beta-blockers in the acute management of STEMI?

A
  • block the beta-adrenergic receptors in the heart
  • prevents effects of sympathetic stimulation
  • involves release of norepinephrine

leads to:
- red HR
- red myocardial contractility
- dec BP

30
Q

How does the presence of ST-segment elevation in STEMI affect the urgency of treatment compared to NSTEMI?

A

ST elevation in STEMI - complete occlusion - full-thickness (transmural) myocardial infarction.

NSTEMI - blockage is partial - not full thickness

31
Q

What is the role of angiotensin-converting enzyme (ACE) inhibitors in the management of STEMI?

A

prevent angiotensin I - angiotensin II

effects:
- vasodilation - reducing afterload
- red fluid retention - low BV - reduce oedema

32
Q

What is the role of statins in the management of STEMI?

A

HMG-CoA reductase inhibitors:
(responsible for cholesterol synthesis)

  • lowering cholesterol levels
  • anti-inflammatory effects
  • improve endothelial function
  • slows progression of atherosclerosis
33
Q

What is the role of morphine in the acute management of STEMI? (3)

A
  • pain relief
  • decreased sympathetic response
  • vasodilation
34
Q

which parts of an ECG correlate with which coronary arteries?

A

V1-V4 - left anterior descending
II, III, aVF - right coronary
I, V5-6 - left circumflex